JESSICA TREAT: Open Payments
NPI 1043840457 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,310 in 152 payments from 21 companies in 2025. Trend: 2023 $2,491 · 2024 $2,444 · 2025 $3,310
Food & beverage: $3,133Education: $177
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 26 | $464 |
| AstraZeneca Pharmaceuticals LP | 18 | $432 |
| Actelion Pharmaceuticals US, Inc. | 9 | $344 |
| Paratek Pharmaceuticals, Inc. | 6 | $233 |
| GENZYME CORPORATION | 12 | $218 |
| Mallinckrodt Hospital Products Inc. | 7 | $187 |
| Regeneron Healthcare Solutions, Inc. | 12 | $184 |
| Verona Pharma, Inc. | 11 | $168 |
| Insmed, Inc. | 9 | $164 |
| Viatris Specialty LLC | 9 | $157 |
Products named: DUPIXENT, BREZTRI, TRELEGY ELLIPTA, NUCALA, NUZYRA, ACTHAR, UPTRAVI, Ohtuvayre.
Industry payments across AR — which companies pay providers there.
